Overview

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

Status:
Completed

Trial end date:
2004-11-01

Target enrollment:

Participant gender:

Summary

Seven-month study in pediatric patients (2-11 years) with moderate to severe AD who were considered to benefit from vaccination to prevent invasive disease caused by Neisseria meningitides serogroup C.

Phase:

Phase 2

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Butyric Acid
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Hydrocortisone-17-butyrate
Tacrolimus
Vaccines